Review rejects link between statin use and memory loss

11/18/2013 | HealthDay News

An analysis of data from 57 studies found that statin use was not associated with an increased risk of memory loss or cognitive decline, contradicting a February 2012 warning from the FDA. Some of the research reviewed found that statin therapy reduced dementia risk by 13% and Alzheimer's disease risk by 21%, researchers said. Researchers also looked at FDA data and did not find any differences in mental decline between statin users and those taking a pair of drugs not linked with mental decline. The findings were published in Annals of Internal Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN